alexa Application of new cholesterol guidelines to a population-based sample.
General Science

General Science

Journal of Forensic Biomechanics

Author(s): Pencina MJ, NavarBoggan AM, D Agostino RB Sr

Abstract Share this page

The ACC-AHA new guidelines for management of cholesterol were released in November of 2013. The new guidelines recommended treatment of patients with LDL cholesterol of 70 mg per deciliter if they have either diabetes or a ten-year risk of cardiovascular disease of 7.5% or more. In addition, the new guidelines expanded the treatment recommendations for statin therapy to all patients with known cardiovascular disease regardless of the LDL cholesterol level. The authors utilized National Health and Nutrition Examination Surveys (NHANES) to estimate the number of persons in the United States for whom statin therapy would be recommended on the basis of the new guidelines as compared with the previous guidelines. NHANES data from 2005 to 2010 was used. Data provided a risk-factor profile of persons for whom statin therapy would be recommended under the new ACC-AHA guidelines as compared with the Third Adult Treatment panel (ATP-III) of the National Cholesterol Education Program. Data was then extrapolated to a population of 115.4 million U.S. adults between the ages of 40 and 75 years. Compared with ATP-III guidelines, the new guidelines would increase the number of U.S. adults receiving or eligible for statin therapy from 43.2 million (37.5%) to 56.0 million (48.6%). 10.4 million of this 12.8 million increase would occur among adults without cardiovascular disease. Among adults between the ages of 60 and 75 years without cardiovascular disease not receiving statin therapy, the percentage that would be eligible for such therapy would increase from 30.4% to 87.4% among men and from 21.2% to 53.6% among women. This effect is driven largely by the increased number of adults who would be classified solely on the basis of their estimated ten-year risk of a cardiovascular event. Those eligible for statin therapy would include more men than women and persons with a higher blood pressure but a markedly lower level of LDL cholesterol.

  • To read the full article Visit
  • Open Access
This article was published in N Engl J Med and referenced in Journal of Forensic Biomechanics

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords